Pacemaker Implantation — Procedure Guide, Recovery & Risks | MyMedicPlus
Quick Facts
What Is a Pacemaker?
A pacemaker is a small battery-powered cardiac implantable electronic device (CIED) that monitors heart rhythm and delivers electrical impulses to maintain an adequate heart rate. Developed over 50 years, modern devices include single-chamber, dual-chamber, biventricular (CRT-P), and leadless pacemakers.
Who Needs This Procedure?
Pacemaker implantation is indicated for symptomatic bradycardia from sick sinus syndrome or atrioventricular block, high-degree AV block (second-degree Mobitz II or third-degree), chronotropic incompetence, carotid sinus hypersensitivity, and cardiac resynchronisation therapy in heart failure with bundle branch block.
How the Procedure Is Performed
Under local anaesthesia and sedation, a subclavian or cephalic vein puncture provides venous access. Fluoroscopy guides lead(s) to the right ventricle and right atrium (or left ventricle via coronary sinus for CRT). The pulse generator is implanted in a subcutaneous prepectoral pocket, tested, and the wound closed.
Recovery & Aftercare
Patients are monitored overnight and typically discharged the next day. The ipsilateral arm is restricted from overhead movement for 4–6 weeks to allow lead fixation. Device interrogation occurs at 6 weeks, 3 months, then annually. Remote monitoring is available with most modern devices.
Risks & Complications
Risks include pneumothorax (1–2%), haematoma, lead dislodgement (1–3%), infection (0.5–1%), cardiac perforation, and pacemaker syndrome from loss of AV synchrony. Electromagnetic interference from MRI requires MR-conditional device selection.
Results & Success Rates
Pacemaker implantation is highly successful, relieving symptoms of bradycardia in over 95% of patients. Battery longevity is 8–12 years; generator replacement is performed as a minor procedure. CRT-P reduces heart failure hospitalisation by 36% and mortality by 24% in appropriate candidates.
Frequently Asked Questions
References
- Kusumoto FM et al. — 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay, Circulation 2019
- ESC Guidelines on cardiac pacing and cardiac resynchronisation therapy, Eur Heart J 2021
- NICE Guidance TA314 — Dual-chamber pacemakers for symptomatic bradycardia, 2014 (Reviewed 2022)
Medically Reviewed
Our medical content follows strict editorial guidelines to ensure accuracy and reliability.
Up to Date
Last updated: 2026-06-26
Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.
Ready to take the next step?
Connect with top hospitals and specialists. Get personalized guidance for your medical journey.